We have previously shown significant associations in this breast tumour cohort between polymorphisms in the p53, p21 and luteinising hormone receptor genes and various phenotypic features including histological grade, steroid receptor level and tumour size (Powell et al, 2002,2003). This evidence concerns the gene TP53 and neoplasm.